4861-79-4

Basic information

• Product Name: MAGNESIUM METHYL CARBONATE
• Synonyms: methoxy(methylcarbonato-o)-magnesiu;STILES REAGENT;STILE'S REAGENT;STILES' REAGENT;MMC;METHOXYMAGNESIUM METHYL CARBONATE;MAGNESIUM METHYL CARBONATE;METHYL METHOXYMAGNESIUM CARBONATE
• CAS NO: 4861-79-4
• Molecular Formula: CH₃O*C₂H₃O₃*Mg
• Molecular Weight: 130.38
• EINECS: 225-466-4
• Mol File: 4861-79-4.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 378.8°C at 760 mmHg
• Flash Point: 52 °F
• Appearance: /
• Density: 1.103 g/mL at 25 °C
• Vapor Pressure: 2.05E-06mmHg at 25°C
• Refractive Index: 1.556
• BRN: 4342967
• CAS DataBase Reference: MAGNESIUM METHYL CARBONATE(CAS DataBase Reference)
• NIST Chemistry Reference: MAGNESIUM METHYL CARBONATE(4861-79-4)
• EPA Substance Registry System: MAGNESIUM METHYL CARBONATE(4861-79-4)

Safety Data

• Hazard Codes: T,F
• Statements: 45-20/21/22-36/37/38-23/24/25-11-36/38-20/21-61
• Safety Statements: 53-26-27-36/37/39-45-38-16-36/37
• RIDADR: UN 1993 3/PG 3
• WGK Germany: 3
• F: 3-10-21
• TSCA: Yes
• Hazardous Substances Data: 4861-79-4(Hazardous Substances Data)

Usage

Uses

Magnesium Methyl Carbonate Solution (2.0 M in DMF) is used to prepare synthetic oleanane and ursane triterpenoids as active inhibitors of nitric oxide production in mouse macrophages.

InChI:InChI=1/C10H15NO3/c1-11-6-9(13)7-3-4-8(12)10(5-7)14-2/h3-5,9,11-13H,6H2,1-2H3/t9-/m0/s1

Upstream product

• 67-56-1 methanol 
• 124-38-9 carbon dioxide 
• 7439-95-4 magnesium 
• 109-88-6 magnesium methanolate 

Downstream Products

• 4195-31-7 2,4-dioxo-3-phenyl-oxazolidine-5-carboxylic acid 
• 25543-68-4 1,5-dihydroxy-2,6-naphthalenedicarboxylic acid 
• 29285-16-3 3-(4-nitrophenyl)-3-oxopropanoic acid 
• 184001-08-9 5-(4-Acetylamino-phenyl)-3-oxo-pentanoic acid 
• 25928-05-6 dimethyl 2-oxocyclohexane-1,3-dicarboxylate 
• 22775-31-1 2-oxo-cyclohexane-1,3-dicarboxylic acid 
• 1140815-06-0 1-((benzyloxy)carbonyl)-5-(methoxycarbonyl)-4-oxopiperidine-3-carboxylic acid 
• 25555-57-1 CBGA 
• 23978-85-0 Δ⁹-tetrahydrocannabinolic acid 
• 2808-39-1 cannabinolic acid 
• 31932-13-5 CBDVA 
• 1244-58-2 cannabidiolic acid 
• 1108663-01-9 2-oxocyclopentane-1,3-dicarboxylic acid 
• 50882-16-1 2-oxocyclopentane-1-carboxylic acid 

Relevant articles and documents

BIOSYNTHESIS OF CANNABINOID PRODRUGS AND THEIR USE AS THERAPEUTIC AGENTS

The present invention provides methods for producing cannabinoid prodrugs. Also described are pharmaceuticals acceptable compositions of the prodrugs and a system for the large-scale production of the prodrugs.

BIOENZYMATIC SYNTHESIS OF THC-v, CBV AND CBN AND THEIR USE AS THERAPEUTIC AGENTS

The present invention provides methods for producing cannabinoids. More specifically, the invention is directed to the bio-enzymatic synthesis of THC-v, CBV and CBN by contacting a compound according to Formula I with a cannabinoid synthase enzyme. Also described is a system for producing these pharmaceutically important cannabinoids and the use of such cannabinoids as therapeutic agents.

BIOSYNTHESIS OF CANNABINOIDS

The present invention provides methods for producing cannabinoids and cannabinoid analogs as well as a system for producing these compounds. The inventive method is directed to contacting a compound according to Formula I or Formula II with a cannabinoid synthase. Also described is a system for producing cannabinoids and cannabinoid analogs by contacting a THCA synthase with a cannabinoid precursor and modifying at least one property of the reaction mixture to influence the quantity formed of a first cannabinoid relative to the quantity formed of a second cannabinoid.